Small Maf proteins (MafF, MafG, MafK): History, structure and function

Gene

Volumn 586, Issue 2, 2016, Pages 197-205

  Katsuoka, Fumiki ^a   Yamamoto, Masayuki ^a,b  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

bZIP transcription factor; MafF; MafG; MafK; Small Maf

Indexed keywords

BACH TRANSCRIPTION FACTOR; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; HETERODIMER; HOMODIMER; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MAFF; TRANSCRIPTION FACTOR MAFG; TRANSCRIPTION FACTOR MAFK; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; DNA; MAFF PROTEIN, MOUSE; MAFG PROTEIN, MOUSE; MAFK PROTEIN, MOUSE; NUCLEAR PROTEIN; REPRESSOR PROTEIN;

DIMERIZATION; DNA BINDING; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE STRUCTURE; HUMAN; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; ANIMAL; CHEMISTRY; DISEASES; GENETICS; HISTORY; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; DISEASE; DNA; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MAFF TRANSCRIPTION FACTOR; MAFG TRANSCRIPTION FACTOR; MAFK TRANSCRIPTION FACTOR; MICE; NUCLEAR PROTEINS; REPRESSOR PROTEINS;

EID: 84964238183     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2016.03.058     Document Type: Review

References (100)

1. Agrawal, S.A., Anand, D., Siddam, A.D., Kakrana, A., Dash, S., Scheiblin, D.A., Dang, C.A., Terrell, A.M., Waters, S.M., Singh, A., Motohashi, H., Yamamoto, M., Lachke, S.A., Compound mouse mutants of bZIP transcription factors Mafg and Mafk reveal a regulatory network of non-crystallin genes associated with cataract. Hum. Genet. 134 (2015), 717–735, 10.1007/s00439-015-1554-5.
2. Andrews, N.C., Erdjument-Bromage, H., Davidson, M.B., Tempst, P., Orkin, S.H., Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362 (1993), 722–728.
3. Andrews, N.C., Kotkow, K.J., Ney, P.A., Erdjument-Bromage, H., Tempst, P., Orkin, S.H., The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 11488–11492.
4. Bauer, A.K., Cho, H.Y., Miller-Degraff, L., Walker, C., Helms, K., Fostel, J., Yamamoto, M., Kleeberger, S.R., Targeted deletion of Nrf2 reduces urethane-induced lung tumor development in mice. PLoS One, 6, 2011, e26590.
5. Benkhelifa, S., Provot, S., Lecoq, O., Pouponnot, C., Calothy, G., Felder-Schmittbuhl, M.-P., mafA, a novel member of the Maf proto-oncogene family, displays developmental regulation and mitogenic capacity in avian neuroretina cells. Oncogene 17 (1998), 247–254.
6. Blackwell, T.K., Bowerman, B., Priess, J.R., Weintraub, H., Formation of a monomeric DNA binding domain by Skn-1 bZIP and homeodomain elements. Science 266 (1994), 621–628.
7. Carvajal-Yepes, M., Himmelsbach, K., Schaedler, S., Ploen, D., Krause, J., Ludwig, L., Weiss, T., Klingel, K., Hildt, E., Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins. J. Biol. Chem. 286 (2011), 8941–8951.
8. Cho, H.-Y., Marzec, J., Kleeberger, S.R., Functional polymorphisms in NRF2: implications for human disease. Free Radic. Biol. Med. 88 (2015), 362–372.
9. Crawford, D.R., Leahy, K.P., Wang, Y., Schools, G.P., Kochheiser, J.C., Davies, K.J., Oxidative stress induces the levels of a MafG homolog in hamster HA-1 cells. Free Radic. Biol. Med. 21 (1996), 521–525.
10. Cullinan, S.B., Gordan, J.D., Jin, J., Harper, J.W., Diehl, J.A., The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 24 (2004), 8477–8486.
11. de Aguiar Vallim, T.Q., Tarling, E.J., Ahn, H., Hagey, L.R., Romanoski, C.E., Lee, R.G., Graham, M.J., Motohashi, H., Yamamoto, M., Edwards, P.A., MAFG is a transcriptional repressor of bile acid synthesis and metabolism. Cell Metab. 21 (2015), 298–310, 10.1016/j.cmet.2015.01.007.
12. Dhakshinamoorthy, S., Jaiswal, A.K., c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction. Oncogene 21 (2002), 5301–5312.
13. Dhomen, N., Marais, R., New insight into BRAF mutations in cancer. Curr. Opin. Genet. Dev. 17 (2007), 31–39.
14. Enomoto, A., Itoh, K., Nagayoshi, E., Haruta, J., Kimura, T., O'Connor, T., Harada, T., Yamamoto, M., High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59 (2001), 169–177.
15. Fang, M., Ou, J., Hutchinson, L., Green, M.R., The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype. Mol. Cell 55 (2014), 904–915, 10.1016/j.molcel.2014.08.010.
16. Friling, R.S., Bensimon, A., Tichauer, Y., Daniel, V., Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc. Natl. Acad. Sci. U. S. A. 87 (1990), 6258–6262.
17. Fujita, R., Takayama-Tsujimoto, M., Satoh, H., Gutierrez, L., Aburatani, H., Fujii, S., Sarai, A., Bresnick, E.H., Yamamoto, M., Motohashi, H., NF-E2 p45 is important for establishing normal function of platelets. Mol. Cell. Biol. 33 (2013), 2659–2670, 10.1128/MCB.01274-12.
18. Fujiwara, K.T., Kataoka, K., Nishizawa, M., Two new members of the Maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain. Oncogene 8 (1993), 2371–2380.
19. Harder, B., Jiang, T., Wu, T., Tao, S., de la Vega, M.R., Tian, W., Chapman, E., Zhang, D.D., Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention. Biochem. Soc. Trans. 43 (2015), 680–686.
20. Hirotsu, Y., Hataya, N., Katsuoka, F., Yamamoto, M., NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1beta genes. Mol. Cell. Biol. 32 (2012), 2760–2770, 10.1128/MCB.06706-11.
21. Hirotsu, Y., Katsuoka, F., Funayama, R., Nagashima, T., Nishida, Y., Nakayama, K., Engel, J.D., Yamamoto, M., Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res. 40 (2012), 10228–10239, 10.1093/nar/gks827.
22. Hirotsu, Y., Higashi, C., Fukutomi, T., Katsuoka, F., Tsujita, T., Yagishita, Y., Matsuyama, Y., Motohashi, H., Uruno, A., Yamamoto, M., Transcription factor NF-E2-related factor 1 impairs glucose metabolism in mice. Genes Cells 19 (2014), 650–665.
23. Igarashi, K., Kataoka, K., Itoh, K., Hayashi, N., Nishizawa, M., Yamamoto, M., Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature 367 (1994), 568–572, 10.1038/367568a0.
24. Igarashi, K., Itoh, K., Motohashi, H., Hayashi, N., Matuzaki, Y., Nakauchi, H., Nishizawa, M., Yamamoto, M., Activity and expression of murine small Maf family protein MafK. J. Biol. Chem. 270 (1995), 7615–7624.
25. Iida, K., Itoh, K., Maher, J.M., Kumagai, Y., Oyasu, R., Mori, Y., Shimazui, T., Akaza, H., Yamamoto, M., Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis. Carcinogenesis 28 (2007), 2398–2403.
26. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M., Nabeshima, Y., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236 (1997), 313–322.
27. Johnsen, Ø., Murphy, P., Prydz, H., Kolstø, A.-B., Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: binding-site selection and regulation of transcription. Nucleic Acids Res. 26 (1998), 512–520.
28. Kataoka, K., Noda, M., Nishizawa, M., Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol. Cell. Biol. 14 (1994), 700–712.
29. Kataoka, K., Igarashi, K., Itoh, K., Fujiwara, K.T., Noda, M., Yamamoto, M., Nishizawa, M., Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor. Mol. Cell. Biol. 15 (1995), 2180–2190.
30. Katsuoka, F., Motohashi, H., Onodera, K., Suwabe, N., Engel, J.D., Yamamoto, M., One enhancer mediates MafK transcriptional activation in both hematopoietic and cardiac muscle cells. EMBO J. 19 (2000), 2980–2991, 10.1093/emboj/19.12.2980.
31. Katsuoka, F., Motohashi, H., Tamagawa, Y., Kure, S., Igarashi, K., Engel, J.D., Yamamoto, M., Small Maf compound mutants display central nervous system neuronal degeneration, aberrant transcription, and Bach protein mislocalization coincident with myoclonus and abnormal startle response. Mol. Cell. Biol. 23 (2003), 1163–1174.
32. Katsuoka, F., Motohashi, H., Engel, J.D., Yamamoto, M., Nrf2 transcriptionally activates the mafG gene through an antioxidant response element. J. Biol. Chem. 280 (2005), 4483–4490, 10.1074/jbc.M411451200.
33. Katsuoka, F., Motohashi, H., Ishii, T., Aburatani, H., Engel, J.D., Yamamoto, M., Genetic evidence that small Maf proteins are essential for the activation of antioxidant response element-dependent genes. Mol. Cell. Biol. 25 (2005), 8044–8051, 10.1128/MCB.25.18.8044-8051.2005.
34. Kim, J., Kwon, E.Y., Park, S., Kim, J.R., Choi, S.W., Choi, M.S., Kim, S.J., Integrative systems analysis of diet-induced obesity identified a critical transition in the transcriptomes of the murine liver and epididymal white adipose tissue. Int. J. Obes. 40 (2015), 338–345, 10.1038/ijo.2015.147.
35. Kimura, M., Yamamoto, T., Zhang, J., Itoh, K., Kyo, M., Kamiya, T., Aburatani, H., Katsuoka, F., Kurokawa, H., Tanaka, T., Motohashi, H., Yamamoto, M., Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of Maf homodimer. J. Biol. Chem. 282 (2007), 33681–33690, 10.1074/jbc.M706863200.
36. Kobayashi, A., Ito, E., Toki, T., Kogame, K., Takahashi, S., Igarashi, K., Hayashi, N., Yamamoto, M., Molecular cloning and functional characterization of a new Cap ‘n’ collar family transcription factor Nrf3. J. Biol. Chem. 274 (1999), 6443–6452.
37. Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., Yamamoto, M., Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24 (2004), 7130–7139.
38. Kobayashi, A., Tsukide, T., Miyasaka, T., Morita, T., Mizoroki, T., Saito, Y., Ihara, Y., Takashima, A., Noguchi, N., Fukamizu, A., Hirotsu, Y., Ohtsuji, M., Katsuoka, F., Yamamoto, M., Central nervous system-specific deletion of transcription factor Nrf1 causes progressive motor neuronal dysfunction. Genes Cells 16 (2011), 692–703, 10.1111/j.1365-2443.2011.01522.x.
39. Kotkow, K.J., Orkin, S.H., Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer. Mol. Cell. Biol. 15 (1995), 4640–4647.
40. Kurokawa, H., Motohashi, H., Sueno, S., Kimura, M., Takagawa, H., Kanno, Y., Yamamoto, M., Tanaka, T., Structural basis of alternative DNA recognition by Maf transcription factors. Mol. Cell. Biol. 29 (2009), 6232–6244, 10.1128/MCB.00708-09.
41. Kusunoki, H., Motohashi, H., Katsuoka, F., Morohashi, A., Yamamoto, M., Tanaka, T., Solution structure of the DNA-binding domain of MafG. Nat. Struct. Biol. 9 (2002), 252–256.
42. LaCasse, E., Lochnan, H., Walker, P., Lefebvre, Y., Identification of binding proteins for nuclear localization signals of the glucocorticoid and thyroid hormone receptors. Endocrinology 132 (1993), 1017–1025.
43. Lee, C.S., Lee, C., Hu, T., Nguyen, J.M., Zhang, J., Martin, M.V., Vawter, M.P., Huang, E.J., Chan, J.Y., Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 8408–8413.
44. Leung, L., Kwong, M., Hou, S., Lee, C., Chan, J.Y., Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J. Biol. Chem. 278 (2003), 48021–48029, 10.1074/jbc.M308439200.
45. Li, X.-M., Hu, Z., Zafar, A.-B., Jorgensen, M.L., Bungert, J., Slayton, W., Intrinsic and extrinsic effects of mafG deficiency on hematopoietic recovery following bone marrow transplant. Exp. Hematol. 38 (2010), 1251–1260.
46. Lu, S.-J., Rowan, S., Bani, M.R., Ben-David, Y., Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 8398–8402.
47. Martínez-Hernández, A., Gutierrez-Malacatt, H., Carrillo-Sánchez, K., Saldaña-Alvarez, Y., Rojas-Ochoa, A., Crespo-Solis, E., Aguayo-González, A., Rosas-López, A., Ayala-Sanchez, J.M., Aquino-Ortega, X., Small MAF genes variants and chronic myeloid leukemia. Eur. J. Haematol. 92 (2014), 35–41.
48. Massrieh, W., Derjuga, A., Doualla-Bell, F., Ku, C.Y., Sanborn, B.M., Blank, V., Regulation of the MAFF transcription factor by proinflammatory cytokines in myometrial cells. Biol. Reprod. 74 (2006), 699–705, 10.1095/biolreprod.105.045450.
49. Mignotte, V., Eleouet, J.F., Raich, N., Romeo, P.-H., Cis-and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. Proc. Natl. Acad. Sci. U. S. A. 86 (1989), 6548–6552.
50. Mignotte, V., Wall, L., Grosveld, F., Romeo, P.-H., Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene. Nucleic Acids Res. 17 (1989), 37–54.
51. Mimura, J., Itoh, K., Role of Nrf2 in the pathogenesis of atherosclerosis. Free Radic. Biol. Med. 88 (2015), 221–232.
52. Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., Motohashi, H., Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22 (2012), 66–79, 10.1016/j.ccr.2012.05.016.
53. Moran, J.A., Mulcahy, R.T., Differential induction of mafF, mafG and mafK expression by electrophile-response-element activators. Biochem. J. 361 (2002), 371–377.
54. Motohashi, H., Igarashi, K., Onodera, K., Takahashi, S., Ohtani, H., Nakafuku, M., Nishizawa, M., Engel, J.D., Yamamoto, M., Mesodermal-vs. neuronal-specific expression of MafK is elicited by different promoters. Genes Cells 1 (1996), 223–238.
55. Motohashi, H., Ohta, J., Douglas Engel, J., Yamamoto, M., A core region of the mafK gene IN promoter directs neurone-specific transcription in vivo. Genes Cells 3 (1998), 671–684.
56. Motohashi, H., Katsuoka, F., Shavit, J.A., Engel, J.D., Yamamoto, M., Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins. Cell 103 (2000), 865–876.
57. Motohashi, H., Katsuoka, F., Engel, J.D., Yamamoto, M., Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 6379–6384, 10.1073/pnas.0305902101.
58. Motohashi, H., Katsuoka, F., Miyoshi, C., Uchimura, Y., Saitoh, H., Francastel, C., Engel, J.D., Yamamoto, M., MafG sumoylation is required for active transcriptional repression. Mol. Cell. Biol. 26 (2006), 4652–4663, 10.1128/MCB.02193-05.
59. Motohashi, H., Fujita, R., Takayama, M., Inoue, A., Katsuoka, F., Bresnick, E.H., Yamamoto, M., Molecular determinants for small Maf protein control of platelet production. Mol. Cell. Biol. 31 (2011), 151–162, 10.1128/MCB.00798-10.
60. Murakami, S., Shimizu, R., Romeo, P.H., Yamamoto, M., Motohashi, H., Keap1–Nrf2 system regulates cell fate determination of hematopoietic stem cells. Genes Cells 19 (2014), 239–253.
61. Muto, A., Hoshino, H., Madisen, L., Yanai, N., Obinata, M., Karasuyama, H., Hayashi, N., Nakauchi, H., Yamamoto, M., Groudine, M., Igarashi, K., Identification of Bach2 as a B-cell-specific partner for small Maf proteins that negatively regulate the immunoglobulin heavy chain gene 3′ enhancer. EMBO J. 17 (1998), 5734–5743, 10.1093/emboj/17.19.5734.
62. Muto, A., Tashiro, S., Nakajima, O., Hoshino, H., Takahashi, S., Sakoda, E., Ikebe, D., Yamamoto, M., Igarashi, K., The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 429 (2004), 566–571, 10.1038/nature02596.
63. Newman, J.R., Keating, A.E., Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 300 (2003), 2097–2101, 10.1126/science.1084648.
64. Ney, P.A., Andrews, N.C., Jane, S.M., Safer, B., Purucker, M.E., Weremowicz, S., Morton, C.C., Goff, S.C., Orkin, S.H., Nienhuis, A.W., Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner. Mol. Cell. Biol. 13 (1993), 5604–5612.
65. Nishizawa, M., Kataoka, K., Goto, N., Fujiwara, K.T., Kawai, S., v-maf, a viral oncogene that encodes a “leucine zipper” motif. Proc. Natl. Acad. Sci. U. S. A. 86 (1989), 7711–7715.
66. Nomoto, H., Kondo, T., Miyoshi, H., Nakamura, A., Hida, Y., Yamashita, K., Sharma, A.J., Atsumi, T., Inhibition of small Maf function in pancreatic beta-cells improves glucose tolerance through the enhancement of insulin gene transcription and insulin secretion. Endocrinology 156 (2015), 3570–3580, 10.1210/en.2014-1906.
67. Ohtsuji, M., Katsuoka, F., Kobayashi, A., Aburatani, H., Hayes, J.D., Yamamoto, M., Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J. Biol. Chem. 283 (2008), 33554–33562.
68. Okita, Y., Kamoshida, A., Suzuki, H., Itoh, K., Motohashi, H., Igarashi, K., Yamamoto, M., Ogami, T., Koinuma, D., Kato, M., Transforming growth factor-beta induces transcription factors MafK and Bach1 to suppress expression of the heme oxygenase-1 gene. J. Biol. Chem. 288 (2013), 20658–20667, 10.1074/jbc.M113.450478.
69. Ono, Y., Wang, Y., Suzuki, H., Okamoto, S., Ikeda, Y., Murata, M., Poncz, M., Matsubara, Y., Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf. Blood 120 (2012), 3812–3821, 10.1182/blood-2012-02-413617.
70. Onodera, K., Shavit, J.A., Motohashi, H., Katsuoka, F., Akasaka, J.E., Engel, J.D., Yamamoto, M., Characterization of the murine mafF gene. J. Biol. Chem. 274 (1999), 21162–21169.
71. Onodera, K., Shavit, J.A., Motohashi, H., Yamamoto, M., Engel, J.D., Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice. EMBO J. 19 (2000), 1335–1345, 10.1093/emboj/19.6.1335.
72. Otsuki, A., Suzuki, M., Katsuoka, F., Tsuchida, K., Suda, H., Morita, M., Shimizu, R., Yamamoto, M., Unique cistrome defined as CsMBE is strictly required for Nrf2-sMaf heterodimer function in cytoprotection. Free Radic. Biol. Med. 91 (2016), 45–57.
73. Oyake, T., Itoh, K., Motohashi, H., Hayashi, N., Hoshino, H., Nishizawa, M., Yamamoto, M., Igarashi, K., Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol. Cell. Biol. 16 (1996), 6083–6095.
74. Petryszak, R., Burdett, T., Fiorelli, B., Fonseca, N.A., Gonzalez-Porta, M., Hastings, E., Huber, W., Jupp, S., Keays, M., Kryvych, N., Expression Atlas update—a database of gene and transcript expression from microarray-and sequencing-based functional genomics experiments. Nucleic Acids Res. 42 (2013), D926–D932.
75. Raich, N., Enver, T., Nakamoto, B., Josephson, B., Papayannopoulou, T., Stamatoyannopoulos, G., Autonomous developmental control of human embryonic globin gene switching in transgenic mice. Science 250 (1990), 1147–1149.
76. Ro, Y.T., Jang, B.K., Shin, C.Y., Park, E.U., Kim, C.G., Yang, S.I., Akt regulates the expression of MafK, synaptotagmin I, and syntenin-1, which play roles in neuronal function. J. Biomed. Sci., 17, 2010, 18, 10.1186/1423-0127-17-18.
77. Romeo, P.-H., Prandini, M.-H., Joulin, V., Mignotte, V., Prenant, M., Vainchenker, W., Uzan, G., Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature 344 (1990), 447–449.
78. Rushmore, T.H., Morton, M.R., Pickett, C.B., The antioxidant responsive element. activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266 (1991), 11632–11639.
79. Sawado, T., Igarashi, K., Groudine, M., Activation of β-major globin gene transcription is associated with recruitment of NF-E2 to the β-globin LCR and gene promoter. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 10226–10231.
80. Scarpulla, R.C., Nuclear control of respiratory chain expression in mammalian cells. J. Bioenerg. Biomembr. 29 (1997), 109–119.
81. Shavit, J.A., Motohashi, H., Onodera, K., Akasaka, J., Yamamoto, M., Engel, J.D., Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice. Genes Dev. 12 (1998), 2164–2174.
82. Shivdasani, R.A., Orkin, S.H., Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 8690–8694.
83. Shivdasani, R.A., Rosenblatt, M.F., Zucker-Franklin, D., Jackson, C.W., Hunt, P., Saris, C.J., Orkin, S.H., Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoeitin/MGDF in megakaryocyte development. Cell 81 (1995), 695–704.
84. Sun, J., Hoshino, H., Takaku, K., Nakajima, O., Muto, A., Suzuki, H., Tashiro, S., Takahashi, S., Shibahara, S., Alam, J., Taketo, M.M., Yamamoto, M., Igarashi, K., Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J. 21 (2002), 5216–5224.
85. Suzuki, T., Yamamoto, M., Molecular basis of the Keap1–Nrf2 system. Free Radic. Biol. Med. 88 (2015), 93–100.
86. Suzuki, T., Shibata, T., Takaya, K., Shiraishi, K., Kohno, T., Kunitoh, H., Tsuta, K., Furuta, K., Goto, K., Hosoda, F., Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels. Mol. Cell. Biol. 33 (2013), 2402–2412.
87. Swaroop, A., Xu, J., Pawar, H., Jackson, A., Skolnick, C., Agarwal, N., A conserved retina-specific gene encodes a basic motif/leucine zipper domain. Proc. Natl. Acad. Sci. U. S. A. 89 (1992), 266–270.
88. Takagi, Y., Kobayashi, M., Li, L., Suzuki, T., Nishikawa, K., Yamamoto, M., MafT, a new member of the small Maf protein family in zebrafish. Biochem. Biophys. Res. Commun. 320 (2004), 62–69, 10.1016/j.bbrc.2004.05.131.
89. Talbot, D., Philipsen, S., Fraser, P., Grosveld, F., Detailed analysis of the site 3 region of the human beta-globin dominant control region. EMBO J., 9, 1990, 2169.
90. Toki, T., Itoh, J., Kitazawa, J., Arai, K., Hatakeyama, K., Akasaka, J., Igarashi, K., Nomura, N., Yokoyama, M., Yamamoto, M., Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif. Oncogene 14 (1997), 1901–1910.
91. Torocsik, B., Angelastro, J.M., Greene, L.A., The basic region and leucine zipper transcription factor MafK is a new nerve growth factor-responsive immediate early gene that regulates neurite outgrowth. J. Neurosci. 22 (2002), 8971–8980.
92. Veraksa, A., McGinnis, N., Li, X., Mohler, J., McGinnis, W., Cap ‘n’ collar B cooperates with a small Maf subunit to specify pharyngeal development and suppress deformed homeotic function in the Drosophila head. Development 127 (2000), 4023–4037.
93. Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., Kotsuji, T., Otsuka, F., Roop, D.R., Harada, T., Engel, J.D., Yamamoto, M., Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35 (2003), 238–245, 10.1038/ng1248.
94. Wang, X., Chorley, B.N., Pittman, G.S., Kleeberger, S.R., Brothers, J. II, Liu, G., Spira, A., Bell, D.A., Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer. PLoS One, 5, 2010, e11934.
95. Wang, R., Zheng, J., Zhang, D.S., Yang, Y.H., Zhao, Z.F., Wnt1-induced MAFK expression promotes osteosarcoma cell proliferation. Genet. Mol. Res. 14 (2015), 7315–7325, 10.4238/2015.July.3.7.
96. Warnatz, H.-J., Schmidt, D., Manke, T., Piccini, I., Sultan, M., Borodina, T., Balzereit, D., Wruck, W., Soldatov, A., Vingron, M., The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycle. J. Biol. Chem. 286 (2011), 23521–23532.
97. Xu, Z., Chen, L., Leung, L., Yen, T.B., Lee, C., Chan, J.Y., Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 4120–4125.
98. Yamazaki, H., Katsuoka, F., Motohashi, H., Engel, J.D., Yamamoto, M., Embryonic lethality and fetal liver apoptosis in mice lacking all three small Maf proteins. Mol. Cell. Biol. 32 (2012), 808–816.
99. Yamazaki, H., Tanji, K., Wakabayashi, K., Matsuura, S., Itoh, K., Role of the Keap1/Nrf2 pathway in neurodegenerative diseases. Pathol. Int. 65 (2015), 210–219.
100. Yang, H., Ko, K., Xia, M., Li, T.W., Oh, P., Li, J., Lu, S.C., Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice. Hepatology 51 (2010), 1291–1301.